title: Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.
authors.affiliation: Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
authors.forename: Sunil
authors.initials: S
authors.lastname: Dogra
authors.affiliation: Manipal Hospital, Bangalore, India.
authors.forename: Krupashankar
authors.initials: K
authors.lastname: D S
authors.affiliation: Bowring and Lady Curzon Hospitals, Bangalore, India.
authors.forename: Leelavathy
authors.initials: L
authors.lastname: Budamakuntla
authors.affiliation: PSG Hospital, Coimbatore, India.
authors.forename: C R
authors.initials: CR
authors.lastname: Srinivas
authors.affiliation: Seth GS Medical College and KEM Hospital, Mumbai, India.
authors.forename: Uday
authors.initials: U
authors.lastname: Khopkar
authors.affiliation: Skin and Laser Centre, New Delhi, India.
authors.forename: Sandesh
authors.initials: S
authors.lastname: Gupta
authors.affiliation: AJ Institute of Medical Sciences, Mangalore, India.
authors.forename: Narendra
authors.initials: N
authors.lastname: Shetty
authors.affiliation: Durgabhai Deshmukh Hospital, Hyderabad, India.
authors.forename: Dasiga Venkata Subrahmanya
authors.initials: DV
authors.lastname: Pratap
authors.affiliation: Kempegowda Institute of Medical Sciences, Bangalore, India.
authors.forename: M G
authors.initials: MG
authors.lastname: Gopal
authors.affiliation: King George Hospital, Visakhapatnam, India.
authors.forename: T Narayana
authors.initials: TN
authors.lastname: Rao
authors.affiliation: Maulana Azad College and Lok Nayak Hospital, New Delhi, India.
authors.forename: Vijay
authors.initials: V
authors.lastname: Garg
authors.affiliation: M S Ramaiah Memorial Hospital, Bangalore, India.
authors.forename: T K
authors.initials: TK
authors.lastname: Sumathy
authors.affiliation: Indushree Skin Clinic, Lucknow, India.
authors.forename: Abir
authors.initials: A
authors.lastname: Saraswat
authors.affiliation: Father Muller Medical College and Hospital, Mangalore, India.
authors.forename: Ramesh
authors.initials: R
authors.lastname: Bhat
authors.affiliation: Grant Medical College and JJ Group of Hospitals, Mumbai, India.
authors.forename: Mahendra
authors.initials: M
authors.lastname: Kura
authors.affiliation: DermaKlinic Skin, Laser and Cosmetic Clinic, Lucknow, India.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Pandey
authors.affiliation: Apollo Hospital, Hyderabad, India.
authors.forename: Radha
authors.initials: R
authors.lastname: Shah
authors.affiliation: Sri Sai Skin Clinic, Hyderabad, India.
authors.forename: Kotla
authors.initials: K
authors.lastname: Sai Krishna
authors.affiliation: Sumana Hospital, Hyderabad, India.
authors.forename: Dalavai
authors.initials: D
authors.lastname: Padmaja
authors.affiliation: Derma Skin Clinic, Hyderabad, India.
authors.forename: G
authors.initials: G
authors.lastname: Manmohan
authors.affiliation: Biocon Research Limited, Bangalore, India.
authors.forename: Ramakrishnan
authors.initials: R
authors.lastname: M S
authors.affiliation: Biocon Research Limited, Bangalore, India. Electronic address: Abhijit.Barve@biocon.com.
authors.forename: Abhijit
authors.initials: A
authors.lastname: Barve
authors.affiliation: Biocon Research Limited, Bangalore, India; Center of Molecular Immunology, Havana, Cuba.
authors.forename: Enrique
authors.initials: E
authors.lastname: Montero
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D020714:Maximum Tolerated Dose; D008875:Middle Aged; D011565:Psoriasis / Q000175:diagnosis* / Q000188:drug therapy*; D011788:Quality of Life; D018570:Risk Assessment; D012720:Severity of Illness Index; D013995:Time; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C000597346:itolizumab